Clearbridge Health Limited (SGX:1H3)

Clearbridge Health Statistics

Total Valuation

SGXC:1H3 has a market cap or net worth of SGD 13.22 million. The enterprise value is 13.98 million.

Market Cap	13.22M
Enterprise Value	13.98M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

SGXC:1H3 has 3.31 billion shares outstanding. The number of shares has increased by 93.03% in one year.

Current Share Class	3.31B
Shares Outstanding	3.31B
Shares Change (YoY)	+93.03%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	25.80%
Owned by Institutions (%)	2.69%
Float	1.83B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.29
PB Ratio	0.95
P/TBV Ratio	10.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.31
EV / Sales	1.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.37

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.10.

Current Ratio	1.73
Quick Ratio	1.39
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-1.18
Interest Coverage	-7.92

Financial Efficiency

Return on equity (ROE) is -25.58% and return on invested capital (ROIC) is -13.29%.

Return on Equity (ROE)	-25.58%
Return on Assets (ROA)	-11.38%
Return on Invested Capital (ROIC)	-13.29%
Return on Capital Employed (ROCE)	-22.68%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	121
Asset Turnover	0.55
Inventory Turnover	22.72

Taxes

Income Tax	-18,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.00% in the last 52 weeks. The beta is 0.36, so SGXC:1H3's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-60.00%
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	57.65
Average Volume (20 Days)	32,132,565

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SGXC:1H3 had revenue of SGD 10.27 million and -2.64 million in losses. Loss per share was -0.00.

Revenue	10.27M
Gross Profit	5.07M
Operating Income	-3.43M
Pretax Income	-3.09M
Net Income	-2.64M
EBITDA	-3.21M
EBIT	-3.43M
Loss Per Share	-0.00

Balance Sheet

The company has 2.41 million in cash and 1.45 million in debt, giving a net cash position of 952,000 or 0.00 per share.

Cash & Cash Equivalents	2.41M
Total Debt	1.45M
Net Cash	952,000
Net Cash Per Share	0.00
Equity (Book Value)	13.92M
Book Value Per Share	0.00
Working Capital	2.17M

Cash Flow

In the last 12 months, operating cash flow was -1.15 million and capital expenditures -84,000, giving a free cash flow of -1.23 million.

Operating Cash Flow	-1.15M
Capital Expenditures	-84,000
Free Cash Flow	-1.23M
FCF Per Share	-0.00

Margins

Gross margin is 49.35%, with operating and profit margins of -33.38% and -25.65%.

Gross Margin	49.35%
Operating Margin	-33.38%
Pretax Margin	-30.11%
Profit Margin	-25.65%
EBITDA Margin	-31.28%
EBIT Margin	-33.38%
FCF Margin	n/a

Dividends & Yields

SGXC:1H3 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-93.03%
Shareholder Yield	n/a
Earnings Yield	-19.93%
FCF Yield	-9.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SGXC:1H3 has an Altman Z-Score of -6.01 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.01
Piotroski F-Score	4